Current Progress Toward a Better Understanding of Drug Disposition Within the Lungs: Summary Proceedings of the First Workshop on Drug Transporters in the Lungs.
暂无分享,去创建一个
Mark Gumbleton | Tetsuya Terasaki | William Couet | Yukio Kato | Ben Forbes | Chris Edwards | Carsten Ehrhardt | Per Bäckman | W. Couet | R. Yumoto | M. Takano | T. Terasaki | T. Nakanishi | Y. Kato | M. Gumbleton | B. Forbes | C. Ehrhardt | Markus Fridén | Ken-ichi Hosoya | Takeo Nakanishi | Mikihisa Takano | Ryoko Yumoto | Chris D. Edwards | P. Bäckman | M. Fridén | K. Hosoya
[1] E. Bäckström,et al. Lung Retention by Lysosomal Trapping of Inhaled Drugs Can Be Predicted In Vitro With Lung Slices. , 2016, Journal of pharmaceutical sciences.
[2] R. Mehta,et al. Effect of verapamil on systemic exposure and safety of umeclidinium and vilanterol: a randomized and open-label study , 2013, International journal of chronic obstructive pulmonary disease.
[3] Ning Li,et al. Tissue distribution and chemical induction of multiple drug resistance genes in rats. , 2002, Drug metabolism and disposition: the biological fate of chemicals.
[4] Lee Campbell,et al. Expression and Transport Functionality of FcRn within Rat Alveolar Epithelium: A Study in Primary Cell Culture and in the Isolated Perfused Lung , 2005, Pharmaceutical Research.
[5] C. Bosquillon,et al. Drug transporters in the lung--do they play a role in the biopharmaceutics of inhaled drugs? , 2010, Journal of pharmaceutical sciences.
[6] Per Bäckman,et al. Predicting Exposure After Oral Inhalation of the Selective Glucocorticoid Receptor Modulator, AZD5423, Based on Dose, Deposition Pattern, and Mechanistic Modeling of Pulmonary Disposition. , 2017, Journal of aerosol medicine and pulmonary drug delivery.
[7] Y. Sugiyama,et al. Brain efflux index as a novel method of analyzing efflux transport at the blood-brain barrier. , 1996, The Journal of pharmacology and experimental therapeutics.
[8] C. Ehrhardt,et al. Beta-2 Adrenergic Agonists Are Substrates and Inhibitors of Human Organic Cation Transporter 1. , 2015, Molecular pharmaceutics.
[9] V. Schuster,et al. Identification and characterization of a prostaglandin transporter. , 1995, Science.
[10] W. Seeger,et al. Potential of the isolated lung technique for the examination of sildenafil absorption from lung-delivered poly(lactide-co-glycolide) microparticles. , 2016, Journal of controlled release : official journal of the Controlled Release Society.
[11] Hans Lennernäs,et al. Drug Absorption from the Isolated Perfused Rat Lung–Correlations with Drug Physicochemical Properties and Epithelial Permeability , 2003, Journal of drug targeting.
[12] D. Roerig,et al. KINETIC CHARACTERIZATION OF P-GLYCOPROTEIN-MEDIATED EFFLUX OF RHODAMINE 6G IN THE INTACT RABBIT LUNG , 2004, Drug Metabolism and Disposition.
[13] H. Koepsell,et al. Polyspecific cation transporters mediate luminal release of acetylcholine from bronchial epithelium. , 2005, American journal of respiratory cell and molecular biology.
[14] M. Melamed,et al. Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues. , 1990, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[15] Nicolas Grégoire,et al. Biopharmaceutical Characterization of Nebulized Antimicrobial Agents in Rats: 2. Colistin , 2014, Antimicrobial Agents and Chemotherapy.
[16] M. Sakagami,et al. Biochemical evidence for transcytotic absorption of polyaspartamide from the rat lung: effects of temperature and metabolic inhibitors. , 2002, Journal of pharmaceutical sciences.
[17] Carsten Ehrhardt,et al. Transport mechanisms at the pulmonary mucosa: implications for drug delivery , 2016, Expert opinion on drug delivery.
[18] B. Forbes,et al. Lack of difference in pulmonary absorption of digoxin, a P-glycoprotein substrate, in mdr1a-deficient and mdr1a-competent mice. , 2008, The Journal of pharmacy and pharmacology.
[19] T. Terasaki,et al. Validation of uPA/SCID Mouse with Humanized Liver as a Human Liver Model: Protein Quantification of Transporters, Cytochromes P450, and UDP-Glucuronosyltransferases by LC-MS/MS , 2014, Drug Metabolism and Disposition.
[20] Terry R Stouch,et al. Progress in understanding the structure-activity relationships of P-glycoprotein. , 2002, Advanced drug delivery reviews.
[21] B. Milleron,et al. MDR1-Pgp 170 expression in human bronchus. , 1997, The European respiratory journal.
[22] M. Gumbleton,et al. Selectivity in the impact of P-glycoprotein upon pulmonary absorption of airway-dosed substrates: a study in ex vivo lung models using chemical inhibition and genetic knockout. , 2013, Journal of pharmaceutical sciences.
[23] Nicolas Grégoire,et al. Biopharmaceutical Characterization of Nebulized Antimicrobial Agents in Rats: 3. Tobramycin , 2014, Antimicrobial Agents and Chemotherapy.
[24] D. Postma,et al. Multidrug resistance related molecules in human and murine lung. , 2002, Journal of clinical pathology.
[25] T. Terasaki,et al. Correlation of Organic Cation/Carnitine Transporter 1 and Multidrug Resistance-Associated Protein 1 Transport Activities With Protein Expression Levels in Primary Cultured Human Tracheal, Bronchial, and Alveolar Epithelial Cells. , 2016, Journal of pharmaceutical sciences.
[26] Timothy G. Turkington,et al. Kinetics of brain nicotine accumulation in dependent and nondependent smokers assessed with PET and cigarettes containing 11C-nicotine , 2010, Proceedings of the National Academy of Sciences.
[27] M. Gumbleton,et al. Absorption of ipratropium and l-carnitine into the pulmonary circulation of the ex-vivo rat lung is driven by passive processes rather than active uptake by OCT/OCTN transporters. , 2015, International journal of pharmaceutics.
[28] R. Yumoto,et al. Expression and function of PEPT2 during transdifferentiation of alveolar epithelial cells. , 2013, Life sciences.
[29] L. Campbell,et al. Constitutive Expression of P-Glycoprotein in Normal Lung Alveolar Epithelium and Functionality in Primary Alveolar Epithelial Cultures , 2003, Journal of Pharmacology and Experimental Therapeutics.
[30] M. Tekin,et al. A mutation in SLC22A4 encoding an organic cation transporter expressed in the cochlea strial endothelium causes human recessive non-syndromic hearing loss DFNB60 , 2016, Human Genetics.
[31] M. Gumbleton,et al. RT-PCR analysis of ABC, SLC and SLCO drug transporters in human lung epithelial cell models. , 2009, The Journal of pharmacy and pharmacology.
[32] Tetsuya Terasaki,et al. Quantitative Atlas of Membrane Transporter Proteins: Development and Application of a Highly Sensitive Simultaneous LC/MS/MS Method Combined with Novel In-silico Peptide Selection Criteria , 2008, Pharmaceutical Research.
[33] T. Terasaki,et al. Quantitative targeted absolute proteomics-based ADME research as a new path to drug discovery and development: methodology, advantages, strategy, and prospects. , 2011, Journal of pharmaceutical sciences.
[34] P. Högger,et al. Methacholine delays pulmonary absorption of inhaled β(2)-agonists due to competition for organic cation/carnitine transporters. , 2012, Pulmonary pharmacology & therapeutics.
[35] S. Rafii,et al. Generation of a human airway epithelium derived basal cell line with multipotent differentiation capacity , 2013, Respiratory Research.
[36] C. Luscombe,et al. Development of a Novel Quantitative Structure-Activity Relationship Model to Accurately Predict Pulmonary Absorption and Replace Routine Use of the Isolated Perfused Respiring Rat Lung Model , 2016, Pharmaceutical Research.
[37] Simon J. F. Macdonald,et al. Analysis of the Calculated Physicochemical Properties of Respiratory Drugs: Can We Design for Inhaled Drugs Yet? , 2009, J. Chem. Inf. Model..
[38] Nilesh Patel,et al. Drug permeability in 16HBE14o- airway cell layers correlates with absorption from the isolated perfused rat lung. , 2005, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[39] K. Bleasby,et al. The organic cation transporter OCT2 mediates the uptake of β‐adrenoceptor antagonists across the apical membrane of renal LLC‐PK1 cell monolayers , 2000, British journal of pharmacology.
[40] D. Pritchard,et al. Polyethylene glycol-drug ester conjugates for prolonged retention of small inhaled drugs in the lung. , 2013, Journal of controlled release : official journal of the Controlled Release Society.
[41] Praveen M. Bahadduri,et al. Bacterial peptide recognition and immune activation facilitated by human peptide transporter PEPT2. , 2008, American journal of respiratory cell and molecular biology.
[42] C. Ehrhardt,et al. Salbutamol is actively absorbed across human bronchial epithelial cell layers. , 2005, Pulmonary pharmacology & therapeutics.
[43] T. Tsuruo,et al. Distribution of multidrug resistance-associated P-glycoprotein in normal and neoplastic human tissue , 1990 .
[44] Nicolas Grégoire,et al. Biopharmaceutical Characterization of Nebulized Antimicrobial Agents in Rats. 4. Aztreonam , 2016, Antimicrobial Agents and Chemotherapy.
[45] C. Ehrhardt,et al. Functional expression of nicotine influx transporter in A549 human alveolar epithelial cells. , 2016, Drug metabolism and pharmacokinetics.
[46] S. Halldorsson,et al. Drug Delivery Characteristics of the Progenitor Bronchial Epithelial Cell Line VA10 , 2012, Pharmaceutical Research.
[47] Ben Forbes,et al. The Isolated Perfused Lung for Drug Absorption Studies , 2008 .
[48] B. Forbes,et al. In vitro and ex vivo methods predict the enhanced lung residence time of liposomal ciprofloxacin formulations for nebulisation. , 2014, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[49] J. Castle,et al. Expression profiles of 50 xenobiotic transporter genes in humans and pre-clinical species: A resource for investigations into drug disposition , 2006, Xenobiotica; the fate of foreign compounds in biological systems.
[50] B. Forbes,et al. A Comparison of Drug Transport in Pulmonary Absorption Models: Isolated Perfused rat Lungs, Respiratory Epithelial Cell Lines and Primary Cell Culture , 2017, Pharmaceutical Research.
[51] Peter R. Byron,et al. Inhaling medicines: delivering drugs to the body through the lungs , 2007, Nature Reviews Drug Discovery.
[52] M. Welsh,et al. Development of cystic fibrosis and noncystic fibrosis airway cell lines. , 2003, American journal of physiology. Lung cellular and molecular physiology.
[53] Ben Forbes,et al. Human respiratory epithelial cell culture for drug delivery applications. , 2005, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[54] T. Nakanishi,et al. Prostaglandin Transporter (PGT/SLCO2A1) Protects the Lung from Bleomycin-Induced Fibrosis , 2015, PloS one.
[55] Michael Levin. Waiver of In Vivo Bioavailability and Bioequivalence Studies for Immediate-Release Solid Oral Dosage Forms Based on a Biopharmaceutics Classification System , 2001 .
[56] T. Terasaki,et al. Pharmacokinetics, Pharmacodynamics and Drug Transport and Metabolism Correlation of Organic Cation/Carnitine Transporter 1 and Multidrug Resistance-Associated Protein 1 Transport Activities With Protein Expression Levels in Primary Cultured Human Tracheal, Bronchial, and Alveolar Epithelial Cells , 2016 .
[57] T. Terasaki,et al. Drug Transporter Protein Quantification of Immortalized Human Lung Cell Lines Derived from Tracheobronchial Epithelial Cells (Calu-3 and BEAS2-B), Bronchiolar-Alveolar Cells (NCI-H292 and NCI-H441), and Alveolar Type II-like Cells (A549) by Liquid Chromatography-Tandem Mass Spectrometry. , 2015, Journal of pharmaceutical sciences.
[58] W. Couet,et al. P-Glycoprotein-Mediated Transport of Moxifloxacin in a Calu-3 Lung Epithelial Cell Model , 2009, Antimicrobial Agents and Chemotherapy.
[59] U. Fischer,et al. Human alveolar epithelial cells expressing tight junctions to model the air-blood barrier. , 2016, ALTEX.
[60] Min-Ki Lee,et al. Air-liquid interface (ALI) culture of human bronchial epithelial cell monolayers as an in vitro model for airway drug transport studies. , 2007, Journal of pharmaceutical sciences.
[61] Bill Newman,et al. Functional variants of OCTN cation transporter genes are associated with Crohn disease , 2004, Nature Genetics.
[62] C. Ehrhardt,et al. In vitro cell culture models for the assessment of pulmonary drug disposition , 2008 .
[63] M. Weiss,et al. Pharmacokinetics of idarubicin in the isolated perfused rat lung: effect of cinchonine and rutin , 2003, Anti-cancer drugs.
[64] S. Golz,et al. Discovery of the ergothioneine transporter. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[65] Margareta Hammarlund-Udenaes,et al. Development of a Novel Lung Slice Methodology for Profiling of Inhaled Compounds. , 2016, Journal of pharmaceutical sciences.
[66] D. Wall,et al. Permeability Characteristics of Calu-3 Human Bronchial Epithelial Cells: In Vitro - In Vivo Correlation to Predict Lung Absorption in Rats , 2002, Journal of drug targeting.
[67] Mark Gumbleton,et al. Challenges in inhaled product development and opportunities for open innovation. , 2011, Advanced drug delivery reviews.
[68] S J Enna,et al. Absorption of saccharides and urea from the rat lung. , 1972, The American journal of physiology.
[69] H. Daniel,et al. The proton oligopeptide cotransporter family SLC15 in physiology and pharmacology , 2004, Pflügers Archiv.
[70] C. Vancheri,et al. The lung as a privileged site for the beneficial actions of PGE2. , 2004, Trends in immunology.
[71] K. Delank,et al. Association of rheumatoid arthritis with ergothioneine levels in red blood cells: a case control study. , 2006, The Journal of rheumatology.
[72] T. Nakanishi,et al. Transport of ipratropium, an anti-chronic obstructive pulmonary disease drug, is mediated by organic cation/carnitine transporters in human bronchial epithelial cells: implications for carrier-mediated pulmonary absorption. , 2010, Molecular pharmaceutics.
[73] R. Yumoto,et al. Comparison of Albumin Uptake in Rat Alveolar Type II and Type I-like Epithelial Cells in Primary Culture , 2008, Pharmaceutical Research.
[74] T. Tsuruo,et al. Distribution of multi-drug resistance-associated P-glycoprotein in normal and neoplastic human tissues. Analysis with 3 monoclonal antibodies recognizing different epitopes of the P-glycoprotein molecule. , 1990, Annals of oncology : official journal of the European Society for Medical Oncology.
[75] T. Terasaki,et al. Blood-to-brain influx transport of nicotine at the rat blood–brain barrier: Involvement of a pyrilamine-sensitive organic cation transport process , 2013, Neurochemistry International.
[76] Yoshinobu Nakamura,et al. OATP2A1/SLCO2A1-mediated prostaglandin E2 loading into intracellular acidic compartments of macrophages contributes to exocytotic secretion. , 2015, Biochemical pharmacology.
[77] Steven K. Huang,et al. Prostaglandin E2 inhibits specific lung fibroblast functions via selective actions of PKA and Epac-1. , 2008, American journal of respiratory cell and molecular biology.
[78] C. Ehrhardt,et al. In vitro cell culture models for the assessment of pulmonary drug disposition. , 2008, Expert opinion on drug metabolism & toxicology.
[79] D. Aronoff,et al. Prostaglandin E(2) inhibits collagen expression and proliferation in patient-derived normal lung fibroblasts via E prostanoid 2 receptor and cAMP signaling. , 2007, American journal of physiology. Lung cellular and molecular physiology.
[80] M. Tomita,et al. Gene Knockout and Metabolome Analysis of Carnitine/Organic Cation Transporter OCTN1 , 2010, Pharmaceutical Research.
[81] J. Duarte,et al. Paraquat Poisonings: Mechanisms of Lung Toxicity, Clinical Features, and Treatment , 2008, Critical reviews in toxicology.
[82] J. Locker,et al. Failure of Postnatal Ductus Arteriosus Closure in Prostaglandin Transporter–Deficient Mice , 2010, Circulation.
[83] H. Koepsell. The SLC22 family with transporters of organic cations, anions and zwitterions. , 2013, Molecular aspects of medicine.
[84] T. Nakanishi,et al. A role of prostaglandin transporter in regulating PGE₂ release from human bronchial epithelial BEAS-2B cells in response to LPS. , 2013, The Journal of endocrinology.
[85] M. Rowland,et al. Physiologically based pharmacokinetic modeling 1: predicting the tissue distribution of moderate-to-strong bases. , 2005, Journal of pharmaceutical sciences.
[86] Nicolas Grégoire,et al. Biopharmaceutical Characterization of Nebulized Antimicrobial Agents in Rats: 1. Ciprofloxacin, Moxifloxacin, and Grepafloxacin , 2014, Antimicrobial Agents and Chemotherapy.
[87] Ken Grime,et al. Optimisation of DMPK by the inhaled route: challenges and approaches. , 2012, Current drug metabolism.
[88] C. Ehrhardt,et al. Organic cation transporters in the blood-air barrier: expression and implications for pulmonary drug delivery. , 2012, Therapeutic delivery.
[89] T. Terasaki,et al. Quantitative Targeted Absolute Proteomics of Transporters and Pharmacoproteomics-Based Reconstruction of P-Glycoprotein Function in Mouse Small Intestine. , 2016, Molecular pharmaceutics.
[90] Tetsuya Terasaki,et al. Quantitative expression of human drug transporter proteins in lung tissues: analysis of regional, gender, and interindividual differences by liquid chromatography-tandem mass spectrometry. , 2013, Journal of pharmaceutical sciences.
[91] T. Terasaki,et al. Pharmacoproteomics-Based Reconstruction of In Vivo P-Glycoprotein Function at Blood-Brain Barrier and Brain Distribution of Substrate Verapamil in Pentylenetetrazole-Kindled Epilepsy, Spontaneous Epilepsy, and Phenytoin Treatment Models , 2014, Drug Metabolism and Disposition.
[92] Carsten Kneuer,et al. Influence of apical fluid volume on the development of functional intercellular junctions in the human epithelial cell line 16HBE14o–: implications for the use of this cell line as an in vitro model for bronchial drug absorption studies , 2002, Cell and Tissue Research.
[93] D. Horn,et al. Mutations in the prostaglandin transporter encoding gene SLCO2A1 Cause primary hypertrophic osteoarthropathy and isolated digital clubbing , 2012, Human mutation.
[94] M. Gumbleton,et al. Spatial expression and functionality of drug transporters in the intact lung: objectives for further research. , 2011, Advanced drug delivery reviews.
[95] Hong Wang,et al. Association of single nucleotide polymorphism rs3792876 in SLC22A4 gene with autoimmune thyroid disease in a Chinese Han population , 2015, BMC Medical Genetics.
[96] S. Randell,et al. Novel human bronchial epithelial cell lines for cystic fibrosis research. , 2009, American journal of physiology. Lung cellular and molecular physiology.
[97] T. Nakanishi,et al. In vivo evidence of organic cation transporter-mediated tracheal accumulation of the anticholinergic agent ipratropium in mice. , 2013, Journal of pharmaceutical sciences.
[98] Claus-Michael Lehr,et al. Scope and relevance of a pulmonary biopharmaceutical classification system AAPS/FDA/USP Workshop March 16-17th, 2015 in Baltimore, MD , 2016 .
[99] Yusuke Nakamura,et al. An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis , 2003, Nature Genetics.
[100] V. Schuster,et al. Cloning, in vitro expression, and tissue distribution of a human prostaglandin transporter cDNA(hPGT). , 1996, The Journal of clinical investigation.
[101] L. Gustavsson,et al. Identification of novel substrates and structure-activity relationship of cellular uptake mediated by human organic cation transporters 1 and 2. , 2013, Journal of medicinal chemistry.
[102] A. Rubbert,et al. Functional role of the 503F variant of the organic cation transporter OCTN1 in Crohn’s disease , 2005, Gut.
[103] A. Lundqvist,et al. Systems Pharmacology Approach for Prediction of Pulmonary and Systemic Pharmacokinetics and Receptor Occupancy of Inhaled Drugs , 2016, CPT: pharmacometrics & systems pharmacology.
[104] M. Gumbleton,et al. P-glycoprotein (MDR1) functional activity in human alveolar epithelial cell monolayers , 2007, Cell and Tissue Research.
[105] C. Ehrhardt. Inhalation Biopharmaceutics: Progress Towards Comprehending the Fate of Inhaled Medicines , 2017, Pharmaceutical Research.
[106] M. Gumbleton,et al. Enhanced pulmonary absorption of a macromolecule through coupling to a sequence-specific phage display-derived peptide. , 2011, Journal of controlled release : official journal of the Controlled Release Society.
[107] Ben Forbes,et al. In‐vitro respiratory drug absorption models possess nominal functional P‐glycoprotein activity , 2009, The Journal of pharmacy and pharmacology.
[108] Hans Lennernäs,et al. Pulmonary absorption rate and bioavailability of drugs in vivo in rats: structure-absorption relationships and physicochemical profiling of inhaled drugs. , 2003, Journal of pharmaceutical sciences.
[109] R. Yumoto,et al. Functional Expression of PEPT2 in the Human Distal Lung Epithelial Cell Line NCl-H441 , 2015, Pharmaceutical Research.
[110] T. Matsui,et al. A Hereditary Enteropathy Caused by Mutations in the SLCO2A1 Gene, Encoding a Prostaglandin Transporter , 2015, PLoS genetics.
[111] C. Ehrhardt,et al. Transport of the fluorescent organic cation 4-(4-(dimethylamino)styryl)-N-methylpyridinium iodide (ASP+) in human respiratory epithelial cells. , 2012, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[112] Sandra A G Visser,et al. Preclinical Experimental and Mathematical Approaches for Assessing Effective Doses of Inhaled Drugs, Using Mometasone to Support Human Dose Predictions. , 2016, Journal of aerosol medicine and pulmonary drug delivery.